X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective.
Gaspar
Hubert B
HB
Molecular Immunology Unit, Institute of Child Health, University College London, United Kingdom. h.gaspar@ich.ac.uk
Sharifi
Reza
R
Gilmour
Kimberly C
KC
Thrasher
Adrian J
AJ
D000293:Adolescent; D000328:Adult; D015703:Antigens, CD; D002352:Carrier Proteins / Q000737:chemistry / Q000235:genetics; D002450:Cell Communication; D002648:Child; D002675:Child, Preschool; D006023:Glycoproteins / Q000737:chemistry / Q000235:genetics; D006801:Humans; D007136:Immunoglobulins / Q000737:chemistry / Q000235:genetics; D047908:Intracellular Signaling Peptides and Proteins; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000235:genetics / Q000276:immunology / Q000628:therapy; D008297:Male; D009154:Mutation / Q000235:genetics; D010375:Pedigree; D011956:Receptors, Cell Surface; D000071179:Signaling Lymphocytic Activation Molecule Associated Protein; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1
D015703:Antigens, CD; D002352:Carrier Proteins; D006023:Glycoproteins; D007136:Immunoglobulins; D047908:Intracellular Signaling Peptides and Proteins; D011956:Receptors, Cell Surface; C114953:SH2D1A protein, human; D000071179:Signaling Lymphocytic Activation Molecule Associated Protein; D000071177:Signaling Lymphocytic Activation Molecule Family Member 1